Inhibition of interleukin-1 release and activity by the rat seminal vesicle protein SV-IV.
SV-IV, a 9.8-kd protein isolated from rat seminal vesicle secretion, has been shown to have strong non-species-specific immunosuppressive, anti-inflammatory, antithrombotic, and antiphospholipase A2 properties. The present investigation was undertaken to determine the mechanism of action of its immunosuppressive effects. It was found that SV-IV is a potent inhibitor of interleukin-1 (IL-1) release from lipopolysaccharide (LPS)-activated human adherent monocytes and an effective inhibitor of IL-1-induced thymocyte proliferation. The ability of SV-IV to form a noncovalent dimeric association with IL-1 alpha but not with IL-1 beta, its ability to induce a marked decrease of IL-1 binding to its own receptors on the thymocyte surface, and its capacity to bind specifically to the macrophage plasma membrane might play an important role in the molecular mechanism of these inhibitory effects.
Institute of General Pathology, First Medical School, University of Naples, Italy.
M L
ML
Vuotto
G
G
Peluso
D
D
Mancino
G
G
Colonna
A
A
Facchiano
M T
MT
Ielpo
G
G
Ravagnan
S
S
Metafora
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002448:Cell Adhesion / Q000187:drug effects; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D007375:Interleukin-1 / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D015850:Interleukin-6 / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000502:physiology; D009000:Monocytes / Q000166:cytology; D029584:Prostatic Secretory Proteins; D011506:Proteins / Q000494:pharmacology*; D051381:Rats; D029589:Seminal Plasma Proteins; D012822:Silicon Dioxide / Q000494:pharmacology
D007375:Interleukin-1; D015850:Interleukin-6; D008070:Lipopolysaccharides; D029584:Prostatic Secretory Proteins; D011506:Proteins; D029589:Seminal Plasma Proteins; C043076:beta-microseminoprotein; D012822:Silicon Dioxide